The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study
Background: Type 2 diabetes mellitus (T2DM) is known to require continuous clinical care and management that consumes significant health-care resources. These costs are not well understood, particularly in low- and middle-income countries. Objective: The aim of this study was to estimate the direct...
Main Authors: | Agnes Erzse, Nicholas Stacey, Lumbwe Chola, Aviva Tugendhaft, Melvyn Freeman, Karen Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Global Health Action |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/16549716.2019.1636611 |
Similar Items
-
Economic burden of stroke in a rural South African setting
by: Mandy Maredza, et al.
Published: (2016-06-01) -
Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
by: Ijeoma Edoka, et al.
Published: (2022-08-01) -
Drug costs in context: assessing drug costs in cost-of-illness analyses
by: T Joseph Mattingly II, et al.
Published: (2022-07-01) -
Closing the mental health treatment gap in South Africa: a review of costs and cost-effectiveness
by: Helen Jack, et al.
Published: (2013-05-01) -
Healthcare Expenditures Associated with Heart Failure in Saudi Arabia: A Cost of Illness Study
by: Ahmed Alghamdi, et al.
Published: (2021-08-01)